Allyson Rinderle

Allyson Rinderle is a Managing Director in the Life Sciences team at Bain Capital, a position she has held since October 2022.3 She has an extensive background in healthcare and life sciences investing:

Career History

• Managing Director, Life Sciences at Bain Capital (October 2022 - Present)3
• Principal, Healthcare Growth Equity & Private Equity at KKR & Co. L.P. (August 2017 - September 2022)3
• Vice President at Longitude Capital (July 2016 - July 2017)3
• Analyst at Aisling Capital (November 2011 - July 2014)3
• Investment Banking Analyst at J.P. Morgan (July 2010 - October 2011)3

Education

• MBA from Stanford Graduate School of Business, where she was an Arjay Miller Scholar14
• BS in Biomedical Engineering with distinction from Yale University, graduating magna cum laude, Tau Beta Pi, and Phi Beta Kappa14

Additional Roles

• Director at Paige LLC and PetVet Care Centers LLC2
• Board Advisor at Blavatnik Fund For Innovation At Yale University24

Rinderle's expertise spans various aspects of healthcare investing, including growth equity, private equity, and venture capital in the life sciences sector.123